Latinx Hazardous Drinkers with Clinical Anxiety: Effectiveness Trial of a Personalized Normative Feedback Intervention
Latinx Hazardous Drinkers with Clinical Anxiety: Effectiveness Trial of a Personalized Normative Feedback Intervention
批准号:
10616033
负责人:
MICHAEL J. ZVOLENSKY
金额:
$4.32万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-20 至 2026-05-31
关键词:
AddressAlcohol consumptionAlcoholsAnxietyAreaAttitudeBasic ScienceBehavior TherapyBehavioral MedicineCOVID-19CaringClinicClinical Trials DesignCommunity HealthComplex AnalysisComputersDataDevelopmentEffectivenessEffectiveness of InterventionsEquationExpectancyFeedbackFemaleFocus GroupsFundingFunding OpportunitiesGoalsGrantGuidelinesHappinessHealth PromotionImpairmentIntentionInterventionKnowledgeLatinxLatinx populationLearningMediatingMediator of activation proteinMentorsMexican AmericansModelingMotivationNational Institute on Alcohol Abuse and AlcoholismNational Research Service AwardsOutcomeParticipantPersonal SatisfactionPhasePopulations at RiskPrincipal InvestigatorPublic HealthRandomizedRandomized Clinical TrialsRandomized Controlled TrialsRecoveryReportingResearchResearch Project GrantsResearch SupportSamplingScientistStandardizationStrategic PlanningSupervisionTestingTrainingTranslatingUnderserved PopulationUnited StatesUnited States National Institutes of HealthWomanWorkacceptability and feasibilityalcohol misusealcohol misuse preventionalcohol related consequencesalcohol use disorderanxiety managementanxiety symptomsbasebiobehaviorclinical anxietycomorbiditycompare effectivenesscopingcostdemographicsdesigndrinkingeffectiveness testingeffectiveness trialethnic discriminationexperiencefollow-uphazardous drinkinghealth care settingshealth disparityimprovedinnovationinterestintervention effectmalemeetingsmultilevel analysisnovelparent grantpersonalized normative feedbackprofessorprogramspublic health prioritiespublic health researchresiliencesymposiumtherapy designtherapy development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1. Summary of Funded Grant
Despite being one of the largest and fastest-growing demographics in the United States (US), Latinx
persons experience striking health disparities, particularly in terms of hazardous drinking and co-occurring
clinical anxiety. No interventions to date have targeted hazardous drinking in the context of clinical anxiety
among Latinx persons. The current R01 proposal builds upon our past work by developing a brief, single-
session, computer-based, personalized feedback intervention (PFI) designed to enhance knowledge regarding
adverse anxiety-alcohol interrelations, increase motivation and intention to reduce hazardous drinking, and
reduce positive attitudes and intentions regarding the use of alcohol for anxiety.
Specifically, we propose to develop a low-cost, highly disseminatable, integrated PFI for Latinx
hazardous drinkers with clinical anxiety (AA-PFI 1.0) that will be implemented and tested for effectiveness in
community-based health clinics. Our approach will follow a staged model consistent with National Institutes of
Health (NIH) guidelines for developing and standardizing behavioral interventions. Phase IA activities will
involve collecting qualitative and quantitative feedback from three iterative focus groups (N = 21) to refine
intervention content and evaluate treatment acceptability and feasibility. Phase IB activities will include a
rigorous randomized clinical trial designed to compare the effectiveness of AA-PFI 2.0 to a control PFI (C-PFI)
among a sample of 250 Latinx hazardous drinkers with clinical anxiety who receive care within community-
based health clinics. This study represents an important and pivotal step in the larger landscape of translating
basic research to more efficacious strategies for reducing hazardous drinking in underserved populations with
biobehavioral comorbidities. The proposed research project supports the 2017-2021 strategic plan of the
National Institute on Alcohol Abuse and Alcoholism (NIAAA) by advancing research in two of the key areas.
First, the current proposal has the end goal of improving strategies to prevent alcohol misuse, alcohol use
disorder, and alcohol-related consequences among an ‘at-risk’ population for these conditions (goal 3).
Second, it enhances the public health impact of NIAAA-supported research by focusing on one of the fastest-
growing and largest demographics in the US who demonstrate disparities in hazardous drinking (goal 5). The
current application aligns with the goals of RFA-AA-21-001 by proposing to examine the effectiveness of a low
cost, highly disseminatable, personalized, culturally adapted PFI for Latinx hazardous drinkers with clinical
anxiety within community-based health clinics. Given the collective public health impact of concurrent anxiety
and alcohol use, we believe the proposed study will yield findings that enhance scientific knowledge, advance
our understanding of mechanisms in anxiety-alcohol use relations, and inform the development of novel
treatments for hazardous drinkers with clinical anxiety that are adaptable and easily implemented across a
variety of healthcare settings. The proposed supplement will expand the examination of the effectiveness of
the intervention by exploring the impact of the culturally tailored PFI on different facets of well-being, and how
changes in well-being are associated with changes in anxiety and alcohol use following the intervention. The
well-being outcomes have previously been found by Drs. Zvolensky and Gallagher to predict resilience to and
recovery from anxiety/alcohol outcomes, so this added component to the parent grant will enhance our
understanding of the potential lasting effects of the intervention while providing a tailored training experience
for Ms. Senger. Regarding her training plan, Ms. Senger will be co-mentored by Drs. Zvolensky and Gallagher
through regular meetings and supervision to provide the ideal blend of expertise needed to support Ms. Senger
in her development as a scientist. In the first year, Ms. Senger will have the opportunity to assist in starting a
randomized controlled trial, author an invited article, and present at a conference. In the second year, she will
have the opportunity learn more complex analyses such as structural equation modeling, co-author an
empirical article, and disseminate her findings at a conference. In the third year, Ms. Senger will assist with
intervention retention, learn multi-level modeling, and develop a National Research Service Award (NRSA)
proposal.
Aim 1. Phase IA: Develop a culturally adapted brief, single-session, integrated, computer-based
anxiety-alcohol PFI (AA-PFI 1.0) designed to (1) enhance knowledge of adverse anxiety-alcohol
interrelations; (2) increase motivation and intention to reduce hazardous drinking; and (3) reduce positive
attitudes and intention regarding alcohol use. This phase will focus on the development and iterative
refinement of the AA-PFI 1.0, using qualitative and quantitative data collected from three focus groups and
feedback from internal and external expert consultants. We will establish feasibility of treatment delivery, participant
acceptability, and potential effect among hazardous drinkers with comorbid clinical anxiety (N = 21).
Aim 2. Phase IB: Conduct a randomized-controlled trial testing the effectiveness of AA-PFI 2.0 (vs. C-
PFI) on motivation/intention to reduce drinking, expectancies for anxiety management via drinking, and
attitudes/intentions regarding alcohol use among Latinx hazardous drinkers with clinical anxiety (N = 250)
PHS 398/2590 (Rev. 09/04, Reissued 4/2006) Page 2
Principal Investigator/Program Director (Last, First, Middle): Zvolensky, Michael J.
within community-based health clinics.
Hypotheses: At post-test, participants randomized to AA-PFI 2.0 (vs. C-PFI) will report:
H1A: greater motivation/intention to reduce drinking to non-hazardous levels
H1B: reduced expectancies of drinking to mitigate/cope with anxiety
H1C: reduced maladaptive attitudes/intentions regarding the use of alcohol
Hypotheses: At 1-, 3-, and 6-month follow-up, participants randomized to AA-PFI 2.0 (vs. C-PFI) will evince:
H2A: a greater degree of change in rates from hazardous to non-hazardous drinking, lower rates of alcohol
consumption (e.g., drinks in the past month), and alcohol-related negative consequences
H2b: reduced anxiety symptoms and impairment from anxiety symptoms
Exploratory Aim 3. Explore change in motivation (H1A), expectancies (H1B), and attitudes/intentions
(H1C) as mediators of 1-3- and 6-month follow-up outcomes.
H3A: Effects of AA-PFI 2.0 (vs. C-PFI) on 1-, 3-, and 6-month follow-up outcomes will be mediated by the
following post-test outcomes: (1) motivation/intention to reduce drinking, (2) expectancies for anxiety-
coping/reduction via drinking, and (3) attitudes/intentions regarding alcohol use (for H2A and H2b).
Exploratory Aim 4. Explore moderators of AA-PFI 2.0 vs. C-PFI effects.
H4A: The effects of AA-PFI 2.0 (vs. C-PFI) on post-test and 1-, 3-, and 6-month follow-up outcomes will be
larger among female (relative to male) participants and Latinx persons who hold stronger values of simpatía.
The effects of AA-PFI 2.0 (vs. C-PFI) on post-test and 1-, 3-, and 6-month follow-up outcomes will be smaller
for those with greater baseline perceived ethnic discrimination and greater baseline COVID-19 worry.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Latinx Hazardous Drinkers with Clinical Anxiety: Effectiveness Trial of a Personalized Normative Feedback Intervention
-
批准号:10836087
-
项目类别:
-
资助金额:$4.32万
-
财政年份:2021
-
负责人:MICHAEL J. ZVOLENSKY
-
依托单位:
Latinx Hazardous Drinkers with Clinical Anxiety: Effectiveness Trial of a Personalized Normative Feedback Intervention
-
批准号:10369165
-
项目类别:
-
资助金额:$14.65万
-
财政年份:2021
-
负责人:MICHAEL J. ZVOLENSKY
-
依托单位:
Latinx Hazardous Drinkers with Clinical Anxiety: Effectiveness Trial of a Personalized Normative Feedback Intervention
-
批准号:10491117
-
项目类别:
-
资助金额:$14.41万
-
财政年份:2021
-
负责人:MICHAEL J. ZVOLENSKY
-
依托单位:
Latinx Hazardous Drinkers with Clinical Anxiety: Effectiveness Trial of a Personalized Normative Feedback Intervention
-
批准号:10631222
-
项目类别:
-
资助金额:$13.91万
-
财政年份:2021
-
负责人:MICHAEL J. ZVOLENSKY
-
依托单位:
Improving Access to Cigarette Cessation Treatment Among African American Smokers: Development and Evaluation of an Integrated mHealth Application
-
批准号:10259792
-
项目类别:
-
资助金额:$45.71万
-
财政年份:2020
-
负责人:MICHAEL J. ZVOLENSKY
-
依托单位:
Improving Access to Cigarette Cessation Treatment Among African American Smokers: Development and Evaluation of an Integrated mHealth Application
-
批准号:10381567
-
项目类别:
-
资助金额:$40.34万
-
财政年份:2020
-
负责人:MICHAEL J. ZVOLENSKY
-
依托单位:
Improving Access to Cigarette Cessation Treatment Among African American Smokers: Development and Evaluation of an Integrated mHealth Application
-
批准号:10644994
-
项目类别:
-
资助金额:$61.55万
-
财政年份:2020
-
负责人:MICHAEL J. ZVOLENSKY
-
依托单位:
Integrated Smoking Cessation Treatment for Emotional Dysregulation
-
批准号:8423889
-
项目类别:
-
资助金额:$22.54万
-
财政年份:2013
-
负责人:MICHAEL J. ZVOLENSKY
-
依托单位:
Integrated Smoking Cessation Treatment for Emotional Dysregulation
-
批准号:8650809
-
项目类别:
-
资助金额:$21.9万
-
财政年份:2013
-
负责人:MICHAEL J. ZVOLENSKY
-
依托单位:
Smoking-Based Prevention Program for Panic Disorder
-
批准号:7541070
-
项目类别:
-
资助金额:$1.86万
-
财政年份:2007
-
负责人:MICHAEL J. ZVOLENSKY
-
依托单位:
Smoking-Based Prevention Program for Panic Disorder
-
批准号:7591627
-
项目类别:
-
资助金额:$62.3万
-
财政年份:2007
-
负责人:MICHAEL J. ZVOLENSKY
-
依托单位:
Smoking-Based Prevention Program for Panic Disorder
-
批准号:7252740
-
项目类别:
-
资助金额:$58.93万
-
财政年份:2007
-
负责人:MICHAEL J. ZVOLENSKY
-
依托单位:
Smoking-Based Prevention Program for Panic Disorder
-
批准号:7798090
-
项目类别:
-
资助金额:$58.57万
-
财政年份:2007
-
负责人:MICHAEL J. ZVOLENSKY
-
依托单位:
Smoking-Based Prevention Program for Panic Disorder
-
批准号:7369806
-
项目类别:
-
资助金额:$60.73万
-
财政年份:2007
-
负责人:MICHAEL J. ZVOLENSKY
-
依托单位:
Smoking and Panic Vulnerability
-
批准号:6912949
-
项目类别:
-
资助金额:$7.6万
-
财政年份:2005
-
负责人:MICHAEL J. ZVOLENSKY
-
依托单位:
Anxiety Sensitivity and Smoking
-
批准号:7111799
-
项目类别:
-
资助金额:$37.11万
-
财政年份:2005
-
负责人:MICHAEL J. ZVOLENSKY
-
依托单位:
Anxiety Sensitivity and Smoking
-
批准号:7242533
-
项目类别:
-
资助金额:$40.13万
-
财政年份:2005
-
负责人:MICHAEL J. ZVOLENSKY
-
依托单位:
Smoking and Panic Vulnerability
-
批准号:7092246
-
项目类别:
-
资助金额:$5.86万
-
财政年份:2005
-
负责人:MICHAEL J. ZVOLENSKY
-
依托单位:
Anxiety Sensitivity and Smoking
-
批准号:7270877
-
项目类别:
-
资助金额:$4.1万
-
财政年份:2005
-
负责人:MICHAEL J. ZVOLENSKY
-
依托单位:
Anxiety Sensitivity and Smoking
-
批准号:6985618
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2005
-
负责人:MICHAEL J. ZVOLENSKY
-
依托单位:
海外基金